Metrogyl DG Gel is a topical pharmaceutical formulation combining Chlorhexidine Gluconate (0.25% w/w) and Metronidazole (1% w/w), designed for the effective management of bacterial infections and inflammatory conditions of the oral cavity and skin. Chlorhexidine Gluconate acts as a broad-spectrum antiseptic, exhibiting potent bactericidal activity against gram-positive and gram-negative organisms by disrupting microbial cell membranes. Metronidazole, a nitroimidazole antibiotic, provides targeted action against anaerobic bacteria and protozoa by inhibiting nucleic acid synthesis, thereby reducing infection and inflammation. The synergistic effect of these two active ingredients makes Metrogyl DG Gel particularly useful in treating gingivitis, periodontitis, dental plaque, and other localized infections where anaerobic bacteria predominate. The gel formulation allows for localized application, ensuring high concentration at the site of infection with minimal systemic absorption, thus reducing the risk of systemic side effects. Metrogyl DG Gel is indicated for use in dental practice for pre- and post-operative care, as well as in dermatological conditions involving bacterial colonization. It should be used as directed by a healthcare professional, avoiding contact with eyes and mucous membranes other than the intended site of application. Regular use as prescribed enhances therapeutic outcomes and supports oral and skin health.